LONDON (Thomson Financial) - Johnson & Johnson said the US Food and Drug has granted accelerated approval to the anti-HIV medication Intelence tablets, developed by Johnson & Johnson unit Tibotec, a division of Ortho Biotech Products LP.
The drug is used as part of HIV combination therapy, Johnson & Johnson said.
FDA accelerated approval procedures allow for earlier approval of drugs that provide a meaningful therapeutic benefit over existing treatment for serious or life-threatening diseases. tf.TFN-Europe_newsdesk@thomson.com vs COPYRIGHT Copyright Thomson Financial News Limited 2007. All rights reserved. The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.